# Personalization of Opioid Prescription Following Orthognathic Surgery

> **NCT05708521** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Nova Scotia Health Authority** · enrollment: 201 (actual)

## Conditions studied

- Pain, Postoperative
- Orthognathic Surgery
- Opioid Use
- Patient Satisfaction
- Opioid Use Disorder

## Interventions

- **DRUG:** Personalization of dose and frequency and instituting a tapering protocol of hydromorphone post-orthognathic surgery
- **DRUG:** Standardized dose and frequency of hydromorphone with no tapering post-orthognathic surgery

## Key facts

- **NCT ID:** NCT05708521
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-04-24
- **Primary completion:** 2024-05-30
- **Final completion:** 2026-05-01
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2025-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05708521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05708521, "Personalization of Opioid Prescription Following Orthognathic Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05708521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*